Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba +70 more·2020·Cell

Cited by (1,002)

Items 701–800 of 1,002

  1. Control of an Epidemic With Endogenous Treatment Capability Under Popular Discontent and Social Fatigue
    Fouad El Ouardighi, Eugene Khmelnitsky, SURESH P. SETHI · 2020 · Production and Operations Management
  2. Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
    Dimitri Poddighe, Elena Fedorovna Kovzel · 2021 · Journal of Inflammation Research
  3. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing
    Ping-Sen Zhao, J. Zou, Fan Zhou, Yanyan Zhu, Q. Song, Dong-Dong Yu, Xiang-Pan Li · 2021 · International Immunopharmacology
  4. Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
    Justyna Sieber, Margareta Mayer, Klara Schmidthaler, Sonja Kopanja, Jeremy Vann Camp, Amelie Popovitsch, Varsha Dwivedi, Jakub Hoz, Anja Schoof, Lukas Weseslindtner et al. · 2022 · Frontiers in Immunology
  5. Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice
    Anran Shen, Xiaoxiao Jin, Tao‐Tao Tang, Yan Ding, Xiao-Tao Liu, Xin Zhong, Yandan Wu, Xuelian Han, Guangyu Zhao, Chuanlai Shen et al. · 2022 · International Journal of Nanomedicine
  6. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
    Yun Qiang Xia, Ren-qi Yao, Pengyue Zhao, Zhengbo Tao, Liyu Zheng, Huiting Zhou, Yong-ming Yao, Xuemin Song · 2022 · Frontiers in Public Health
  7. SARS-CoV-2 infection and immune responses
    Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, Susan L. Baldwin, Rhea N. Coler · 2023 · AIMS Microbiology
  8. Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
    Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Angela M. Cheung, Eustache Paramithiotis et al. · 2023 · BMC Immunology
  9. The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
    M. Good, M. Hawkes · 2020 · mBio
  10. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
    Min‐Seok Rha, A Reum Kim, Eui‐Cheol Shin · 2021 · Immune Network
  11. Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals
    Norihide Jo, Rui Zhang, Hideki Ueno, Takuya Yamamoto, Daniela Weiskopf, Miki Nagao, Shinya Yamanaka, Yoko Hamazaki · 2021 · Frontiers in Aging
  12. Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19
    Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna M. Horner, Alyssa D. Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri et al. · 2022 · JCI Insight
  13. A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients
    Alexandre Favà, Laura Donadeu, Thomas Jouvé, José González‐Costello, Laura Lladó, Carolina Santana, Néstor Toapanta, Manuel Comabella, Vincent Pernin, Carme Facundo et al. · 2022 · Kidney International
  14. Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunity
    Yoshida, Akiho, Okamura, Shinya, Torii, Shiho, Komatsu, Sayuri, Miyazato, Paola, Sasaki, Hitomi, Ueno, Shiori, Suzuki, Hidehiko, Kamitani, Wataru, Ono, Chikako et al. · 2022 · iScience
  15. Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
    Isaac Kyei-Barffour, Samuel Akwetey Addo, E. Aninagyei, George Ghartey-Kwansah, D. O. Acheampong · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  16. Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron
    Yu Gao, Curtis Cai, Alba Grifoni, Thomas R Müller, Julia Niessl, Anna Olofsson, Marion Humbert, Lotta Hansson, Anders Österborg, Peter Bergman et al. · 2022 · Nature Medicine
  17. A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection
    Mats O. Beckman, Sven Nyrén, Anna Kistner · 2020 · Thrombosis Journal
  18. Immune response to COVID-19 in older adults
    Mladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Janko Nikolich‐Žugich · 2021 · The Journal of Heart and Lung Transplantation
  19. Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countries
    Asim Hussain, Hamza Rafeeq, Hafiza Memoona Asif, Sumaira Shabbir, Muhammad Bilal, Sikandar Imamsab Mulla, Marcelo Franco, Hafiz M.N. Iqbal · 2021 · International Immunopharmacology
  20. SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
    Archana Panikkar, Katie E. Lineburg, Jyothy Raju, Keng Yih Chew, George R. Ambalathingal, Sweera Rehan, Srividhya Swaminathan, Pauline Crooks, Laëtitia Le Texier, Leone Beagley et al. · 2022 · PLoS Pathogens
  21. Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine
    Kristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, Elizabeth B. Lorentz, Jay T. Evans, David J. Burkhart · 2022 · Pharmaceutics
  22. The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update
    Saade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor Orifovna Bafoeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei et al. · 2022 · Journal of Medical Virology
  23. Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
    Исакова-Сивак Ирина Николаевна, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria А. Mezhenskaya, Ekaterina A. Bazhenova, Elena V. Krutikova, Tatiana S. Kotomina, Прокопенко Полина Игоревна, Bogdan Neterebskii et al. · 2022 · Vaccines
  24. Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
    Ellen C. Hughes, Julien A R Amat, Joanne Haney, Yasmin A. Parr, Nicola A. Logan, Norah E. Palmateer, Sema Nickbakhsh, Antonia Ying Wai Ho, Peter Cherepanov, Annachiara Rosa et al. · 2020 · The Journal of Infectious Diseases
  25. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
    A. Scaglione, S. Opp, A. Hurtado, C. Pampeno, Ziyan Lin, Maria G. Noval, Sara A. Thannickal, Kenneth A. Stapleford, D. Meruelo · 2021 · bioRxiv
  26. The danger of the single storyline obfuscating the complexities of managing SARS‐CoV‐2/COVID‐19
    Joachim Peter Sturmberg, Élisabeth Paul, Wim V. Damme, Valéry Ridde, Garrett Wallace Brown, Andreas Kalk · 2021 · Journal of Evaluation in Clinical Practice
  27. Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19
    Thaís Garcias Moreira, Christian D. Gauthier, Liam Murphy, Toby Black Lanser, Anu Paul, Kimble Teixeira Fonseca Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C. Healy et al. · 2023 · Proceedings of the National Academy of Sciences
  28. SARS-CoV-2 specific memory B cells frequency in recovered patient remains stable while antibodies decay over time
    Anna Vaisman‐Mentesh, Yael Dror, Ran Tur‐Kaspa, Dana Markovitch, Tatiana Kournos, Dror Dicker, Yariv Wine · 2020 · medRxiv
  29. First year with COVID-19: Assessment and prospects
    Robert N. Bergquist, Behzad Kiani, Samuel Manda · 2020 · Geospatial health
  30. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells
    Min Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
  31. A clinicopathological description of COVID ‐19‐induced chilblains ( COVID ‐toes) correlated with a published literature review
    Athanassios Kolivras, Curtis T. Thompson, Ievgenia Pastushenko, Marisa Mathieu, P. Bruderer, M. de Vicq de Cumptich, Francesco Feoli, Saadia Harag, Isabelle Meiers, Cathérine Olemans et al. · 2021 · Journal of Cutaneous Pathology
  32. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during Convalescence
    Tongcui Ma, Heeju Ryu, Matthew M. McGregor, Benjamin R. Babcock, Jason A. Neidleman, Guorui Xie, Ashley F. George, Julie Frouard, Victoria Murray, Gurjot Gill et al. · 2021 · The Journal of Immunology
  33. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation
    Thiviya Darmarajan, Keshav Raj Paudel, Mayuren Candasamy, Jestin Chellian, Thiagarajan Madheswaran, Lakshmana Prabu Sakthivel, Bey Hing Goh, Piyush Kumar Gupta, Niraj Kumar Jha, Hari Prasad Devkota et al. · 2022 · Environmental Science and Pollution Research
  34. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
    Niels J. M. Verstegen, Ruth R. Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas M. Ashhurst, Laura Y. L. Kummer, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh et al. · 2022 · eLife
  35. Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine
    Chan Wang, Songhao Yang, Liangwei Duan, Xiancai Du, Jia Tao, Yana Wang, Jihui Yang, Yongxue Lv, Junliang Li, Cuiying Zhang et al. · 2022 · Virology Journal
  36. Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
    Takuto Nogimori, Koichiro Suzuki, Yuji Masuta, Mika Yagoto, Mami Ikeda, Yuki Katayama, Ayaka Washizaki, Hidenori Kanda, Minoru Takada, Shohei Minami et al. · 2023 · Frontiers in Immunology
  37. SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals
    Rongzhang He, Xingyu Zheng, Jian Zhang, Bo Liu, Qijie Wang, Qian Wu, Ziyan Liu, Fangfang Chang, Yabin Hu, Ting Xie et al. · 2023 · Signal Transduction and Targeted Therapy
  38. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients
    Pierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2024 · Frontiers in Immunology
  39. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection
    Gang Yang, Jinpeng Cao, Jian Qin, Xinyue Mei, Shidong Deng, Yingjiao Xia, Jun Zhao, Junxiang Wang, Tao Luan, Daxiang Chen et al. · 2024 · Signal Transduction and Targeted Therapy
  40. A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functions
    Sojeong Kim, Sang Won Lee, June‐Young Koh, Donghoon Choi, Minkyu Heo, Jae‐Yong Chung, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee et al. · 2022 · Blood Advances
  41. Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
    Natalia Egri, Hugo Calderón, Roberto Martínez-Soler, Mario Vazquez, Verónica Gómez‐Caverzaschi, Mariona Pascal, Olga Araújo, Manel Juan, Europa Azucena González‐Navarro, José Hernández‐Rodríguez · 2023 · Frontiers in Immunology
  42. SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
    Ziwei Li, Jing Liu, Hui-Hong Deng, Xuecheng Yang, Hua Wang, Xuemei Feng, Gennadiy Zelinskyy, M. Trilling, K. Sutter, Meng-Ji Lu et al. · 2020 · bioRxiv
  43. Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
    Pauline Vetter, Samuel Cordey, Manuel Schibler, Laure Vieux, Lena Després, Florian Laubscher, Diego O. Andrey, Romain Martischang, Stephan Harbarth, Clémence Cuvelier et al. · 2021 · Clinical Microbiology and Infection
  44. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19
    Mario Fernández‐Ruiz, Beatriz Olea, Estela Giménez, Rocío Laguna‐Goya, Hernando Trujillo, Fernando Caravaca‐Fontán, Eduardo Gutiérrez, Francisco López‐Medrano, María José Remigia, Patricia Almendro-Vázquez et al. · 2021 · Transplantation
  45. Adaptive immunity to human coronaviruses is widespread but low in magnitude
    Hyon‐Xhi Tan, Wen Shi Lee, Kathleen M. Wragg, Christina Nelson, Robyn Esterbauer, Hannah G. Kelly, Thakshila H. Amarasena, Robert M. Jones, Graham Starkey, Bao Zhong Wang et al. · 2021 · Clinical & Translational Immunology
  46. Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
    Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen · 2021 · Frontiers in Immunology
  47. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens
    Ryuta Uraki, Masaki Imai, Mutsumi Ito, Hiroaki Shime, Mizuyu Odanaka, Moe Okuda, Yoshihiro Kawaoka, Sayuri Yamazaki · 2021 · PLoS Pathogens
  48. Utility of Bulk T-Cell Receptor Repertoire Sequencing Analysis in Understanding Immune Responses to COVID-19
    Hannah Kockelbergh, Shelley C. Evans, Tong Deng, Ella Clyne, Anna Kyriakidou, Andreas Economou, Kim Ngan Luu Hoang, Stephen Woodmansey, Andrew D. Foers, Anna Fowler et al. · 2022 · Diagnostics
  49. Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
    Donald J. Alcendor, Patricia Matthews-Juarez, Duane T. Smoot, James E. K. Hildreth, Kimberly D. Lamar, Mohammad Tabatabai, Derek M. Wilus, Paul D. Juárez · 2022 · Vaccines
  50. Bioinformatic and Experimental Analysis of T Cell Immune Reactivity to SARS-CoV-2 and its Variants
    Alison Tarke, Alba Grifoni, Alessandro Sette · 2022 · Frontiers in Bioinformatics
  51. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital
    Vidya Avinash Arankalle, A. G. Kulkarni, Ruta Kulkarni, Sonali Hemant Palkar, Rahul Patil, Jitendra Oswal, Sanjay Kewalchand Lalwani, Akhilesh Chandra Mishra · 2022 · Frontiers in Immunology
  52. Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors
    Chen Jia, Zhi-Guo Zhou, Wenjing Pan, Pan Zhang, Ming Yang, Ming Zhao, Bo Li, Ping Liu, Qian-Qian Zhang, Xiang-long Kong et al. · 2022 · Journal of Medical Virology
  53. SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants
    David B. Reeg, Maike Hofmann, Christoph Neumann‐Haefelin, Robert Thimme, Hendrik Luxenburger · 2023 · Pathogens
  54. Testing for SARS-CoV-2: lessons learned and current use cases
    Elitza S. Theel, James E. Kirby, Nira R. Pollock · 2024 · Clinical Microbiology Reviews
  55. COVID-19: from immune response to clinical intervention
    Zheng-yang Guo, Yanqing Tang, Zi-bo Zhang, Juan Liu, Yuxin Zhuang, Ting Li · 2024 · Precision Clinical Medicine
  56. Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia
    Nikolay S. Markov, Ziyou Ren, Karolina J. Senkow, Rogan A. Grant, Catherine A. Gao, Elizabeth S. Malsin, Lango Sichizya, Hermon G. Kihshen, Kathryn A. Helmin, Milica Jovisic et al. · 2024 · Nature Immunology
  57. Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
    Eva Fisher, Laura Padula, Kristin Podack, Katelyn Elizabeth O’Neill, Matthew M. Seavey, Padmini Jayaraman, Rahul R. Jasuja, Nataša Štrbo · 2021 · Frontiers in Immunology
  58. Compounds of plants with activity against SARS-CoV-2 targets
    Diorge Jônatas Marmitt, Márcia Inês Goettert, Claudete Rempel · 2021 · Expert Review of Clinical Pharmacology
  59. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
    Preeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, N. Khan, A. Chiranjivi, Shailendra Mani, M. Bansal, Prabhanjan Dwivedi, T. Shrivastava, Rajesh Kumar et al. · 2021 · Frontiers in Immunology
  60. A reasoned approach towards administering COVID‐19 vaccines to pregnant women
    Angsumita Pramanick, Abhiram Kanneganti, Jing Lin Jeslyn Wong, Sarah Weiling Li, Pooja Sharma Dimri, Aniza Puteri Mahyuddin, Sailesh Kumar, Sebastian Enrique Illanes, Jerry Kok Yen Chan, Lin Su et al. · 2021 · Prenatal Diagnosis
  61. A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects
    Eszter Somogyi, Zsolt Csiszovszki, Levente Molnár, Orsolya Lőrincz, József Tóth, Sofie Pattijn, Jana Schockaert, Aurélie Mazy, István Miklós, Katalin Pántya et al. · 2021 · Frontiers in Genetics
  62. BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity
    Pilar Vizcarra, Johannes Häemmerle, Héctor Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo, José L. Casado · 2021 · Vaccine
  63. Complexity of immune responses in COVID-19
    Michael William Mather, Laura Jardine, Benjamin James Talks, Louis C. S. Gardner, Muzlifah A. Haniffa · 2021 · Seminars in Immunology
  64. An update on host immunity correlates and prospects of re-infection in COVID-19
    Neema Negi, Shesh Prakash Maurya, Ravinder Singh, Bimal Kumar Das · 2021 · International Reviews of Immunology
  65. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort
    Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, Sotheary Sann, Nisa Ya, Polidy Pean, Philippe Dussart et al. · 2022 · Frontiers in Immunology
  66. The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
    Jean‐Eudes Fahrner, Imran Lahmar, Anne‐Gaëlle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Lyon COVID Study Group, Eric de Sousa et al. · 2022 · Cancer Discovery
  67. Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19
    Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andrés F. Vallejo, Stephen Poole, Nathan James Brendish, Xiaofeng Dong, Catherine S. Hartley, John W. Holloway, Jane S. Lucas et al. · 2022 · Frontiers in Immunology
  68. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
    Paola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Vincenzo Raimondi, Denise Toscani, Jessica Burroughs-Garcìa, Federica Costa, Benedetta Dalla Palma et al. · 2022 · OncoImmunology
  69. Modelling optimal lockdowns with waning immunity
    Aditya Goenka, Lin Liu, Manh‐Hung Nguyen · 2022 · Economic Theory
  70. Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
    Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, Manash Kumar Paul · 2023 · Molecular Immunology
  71. Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants
    Peter A. Sieling, Thomas B. King, Raymond M.H. Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma et al. · 2021 · medRxiv
  72. COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective
    Cavaillon, Jean-Marc, Osuchowski, Marcin F. · 2021 · Journal of Intensive Medicine
  73. COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
    Claudio Giuseppe Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, Carlotta Pausini, Tommaso Guarniero, Wandong Hong, Enrico Giampieri et al. · 2021 · Cytokine
  74. Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort study
    Óscar H. Del Brutto, Aldo F. Costa, Robertino M. Mera, Bettsy Y. Recalde, Javier Arturo Bustos, Hector Hugo Garcia · 2020 · Pathogens and Global Health
  75. COVID-19 and a Green Recovery?
    Aditya Goenka, Lin Liu, Manh‐Hung Nguyen · 2021 · Economic Modelling
  76. Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art
    Andrea Bassi, Teresa Palmira Russo, Giuseppe Argenziano, Carlo Mazzatenta, Elisabetta Venturini, Iria Neri, Vincenzo Piccolo · 2021 · Life
  77. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
    Maria Laura De Angelis, Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero D. Maria, Ann Zeuner · 2021 · Viruses
  78. Clinical Patterns and Morphology of COVID-19 Dermatology
    Ritesh V. Agnihothri, Lindy Peta Fox · 2021 · Dermatologic Clinics
  79. Association of lymphocyte subsets with mortality in severe COVID‐19 pneumonia patients
    Farzaneh Ashrafi, Pardis Nematollahi, Mehrzad Salmasi, Arash Hedayat, Babak Amra · 2021 · Journal of Clinical Laboratory Analysis
  80. Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice
    Hui‐Tsu Lin, Cheng-Cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-An Chen, Jenn‐jong Young, Szu-Cheng Kuo · 2021 · International Journal of Biological Macromolecules
  81. A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
    Bertrand Bellier, Alicia Saura, Lucas A. Luján, Cecilia R. Molina, Hugo Daniel Luján, David Klatzmann · 2022 · Frontiers in Immunology
  82. Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
    Tatjana Schwarz, Carolin Otto, Terry C. Jones, Florence C. Pache, Patrick Schindler, Moritz A. Niederschweiberer, Felix Schmidt, Christian Drosten, Victor M. Corman, Klemens Ruprecht · 2022 · Multiple Sclerosis Journal
  83. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
    Alessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, Rita Casetti, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera et al. · 2022 · Frontiers in Immunology
  84. Cellular and humoral response to the fourth BNT162b2 mRNA COVID‐19 vaccine dose in patients with CLL
    Ohad Benjamini, Rotem Gershon, Erez Bar‐Haim, Yaniv Lustig, Hila Cohen, Ram Doolman, Meirav Kedmi, Elena Ribakovsky, Abraham Kneller, Tammy Hod et al. · 2022 · European Journal Of Haematology
  85. Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity
    Shin‐ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, Kanako Shimizu · 2022 · Inflammation and Regeneration
  86. SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
    Maarten E. Emmelot, Martijn W. Vos, Mardi C. Boer, Nynke Y. Rots, Cécile A. C. M. van Els, Patricia Kaaijk · 2022 · Viruses
  87. A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2
    Xiaoxiao Jin, Xiaotao Kelvin Liu, Chuanlai Shen · 2022 · Virus Research
  88. Durability of immune responses to SARS-CoV-2 infection and vaccination
    Mehul S. Suthar · 2024 · Seminars in Immunology
  89. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2–Induced Cytokine Storm
    Alexandre Eduardo Nowill, Pedro Otavio de Campos-Lima · 2020 · The Journal of Immunology
  90. Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
    Marijn Thijssen, Timothy Devos, Hanieh‐Sadat Ejtahed, Samad Amini‐Bavil‐Olyaee, Ali Akbar Pourfathollah, Mahmoud Reza Pourkarim · 2020 · Microorganisms
  91. Running to Stand Still: Naive CD8+ T Cells Actively Maintain a Program of Quiescence
    Taylah J. Bennett, Vibha Udupa, Stephen T. Turner · 2020 · International Journal of Molecular Sciences
  92. Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation
    Mohammad Sadegh Soltani‐Zangbar, Leili Aghebati Maleki, Mahsa Hajivalili, Mostafa Haji-Fatahaliha, Roza Motavalli, Ata Mahmoodpoor, Hossein Samadi Kafil, Sara Farhang, Ramin Pourakbari, Farhad Jadidi‐Niaragh et al. · 2021 · Gene Reports
  93. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection
    Yifan Wang, Fu‐Gang Duan, Zhu Zhu, Meng Yu, Xiaodong Jia, Hui Dai, Pingzhang Wang, Xiaoyan Qiu, Yinying Lu, Jing Huang · 2021 · Cells
  94. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19
    Jesús Zepeda–Cervantes, Daniel Martínez-Flores, Josué O. Ramírez‐Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis A. Vaca, Rosa Elena Sarmiento Silva · 2022 · Viruses
  95. Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
    María Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, Claudia Pastori, Claude Capron, Arielle R. Rosenberg, Nigel James Temperton et al. · 2022 · Frontiers in Immunology
  96. Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine
    Vanessa Gauttier, Aurore Morello, Isabelle Girault, Caroline Mary, Lyssia Belarif, Ariane Desselle, Emmanuelle Wilhelm, Thomas Bourquard, Sabrina Pengam, Géraldine Teppaz et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Complete Protection of Nasal and Lung Airways Against SARS-CoV-2 Challenge by Antibody Plus Th1 Dominant N- and S-Specific T-Cell Responses to Subcutaneous Prime and Thermally-Stable Oral Boost Bivalent hAd5 Vaccination in an NHP Study
    Elizabeth Gabitzsch, Jeffrey T. Safrit, Mohit Verma, Adrian Rice, Peter A. Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Raymond M.H. Wong et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  98. The benefits of Lactiplantibacillus plantarum: From immunomodulator to vaccine vector
    Joshua Tobias, Stefan Heinl, Kristina Dendinovic, Ajša Ramić, Anna Marlene Schmid, Catherine Daniel, Ursula Wiedermann · 2025 · Immunology Letters
  99. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti–SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September–November 2020
    Hannah E. Segaloff, Devlin Cole, Hannah G. Rosenblum, Christine C. Lee, Clint N. Morgan, Patrick Remington, Collin Pitts, Patrick Kelly, Jake Baggott, Allen Bateman et al. · 2021 · Open Forum Infectious Diseases
  100. The (apparent) antibody paradox in COVID-19
    Rohan Ameratunga, See‐Tarn Woon, Edward Lea, Richard Henderson Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology